X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

EFPIA-PhRMA Principles successfully enable responsible clinical trial data sharing

By Olivia Shopshear  |    November 29, 2017
Stakeholders are gathering in London this week for a workshop entitled Data Anonymization – a Key Enabler for Clinical Data Sharing. The workshop, jointly organized by the European Medicines...   Read More

Guest Post: Film chronicles clinical trials ‘paying it forward’

By Guest Contributor  |    November 28, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Biopharmaceutical industry policies aim to increase access to clinical trial data

By Olivia Shopshear  |    July 27, 2017
Today, a study published in the British Medical Journal (BMJ) sought to audit industry clinical trial disclosure and data sharing policies. The study, entitled Pharmaceutical companies’ policies...   Read More

Guest Post: The Clinical trial experience from a patient & researcher perspective

By Guest Contributor  |    May 5, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Guest Post: Patients as research partners - Rethinking patient access to clinical trial data

By Guest Contributor  |    May 4, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Guest Post: Spotlighting the heroes in clinical trials

By Guest Contributor  |    May 3, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Guest Post: Advancing oncology research through clinical trials

By Guest Contributor  |    May 2, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Clinical Trials Awareness Week: Celebrating the impact of clinical research

By Andrew Powaleny  |    May 1, 2017
Today starts off the beginning of Clinical Trials Awareness Week, which shines a spotlight on how the clinical trials process helps deliver safe, effective medicines to patients.   Read More

Watch: Biomarkers in drug development with Dr. Bernie Zeiher

By Andrew Powaleny  |    February 14, 2017
Biomarkers are powerful tools which are used by medical professionals in many ways, including in the diagnosis of disease, monitoring how a disease is progressing and, if a treatment is given, how...   Read More

The Science of Hope: Understanding biomarkers

By Andrew Powaleny  |    May 18, 2016
In the age of personalized medicine, biomarkers (short for “biological markers”) are emerging as important tools in drug development. A biomarker is a measure or physical sign that can be used to...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates